XML 13 R2.htm IDEA: XBRL DOCUMENT v3.26.1
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
ASSETS    
Cash and cash equivalents $ 6,944 $ 6,322
Restricted cash and equivalents 178,469 165,885
Finance receivables measured at fair value 3,835,789 3,655,855
Furniture and equipment, net 1,342 771
Deferred tax assets, net 16 16
Other assets 30,239 29,344
Total assets 4,052,799 3,858,193
Liabilities    
Accounts payable and accrued expenses 70,261 65,244
Warehouse lines of credit 467,138 324,871
Residual interest financing 181,383 142,982
Securitization trust debt 2,992,157 2,986,574
Subordinated renewable notes 27,508 28,986
Total liabilities 3,738,447 3,548,657
COMMITMENTS AND CONTINGENCIES
Shareholders’ Equity    
Common stock, no par value; authorized 75,000,000 shares; 21,695,835 and 21,842,457 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively 23,703 24,426
Retained earnings 291,924 286,385
Accumulated other comprehensive loss (1,275) (1,275)
Total shareholders’ equity 314,352 309,536
Total liabilities and shareholders’ equity 4,052,799 3,858,193
Preferred Stock [Member]    
Shareholders’ Equity    
Preferred stock, value 0 0
Series A Preferred Stock [Member]    
Shareholders’ Equity    
Preferred stock, value 0 0
Series B Preferred Stock [Member]    
Shareholders’ Equity    
Preferred stock, value $ 0 $ 0